Shisihao Pharmaceutical Group (02005.HK) has obtained drug production registration certificates for calcium gluconate sodium chloride injection (100ml: 1g / 0.8g) and metronidazole sodium chloride injection (100ml: 0.5g / 0.9g).

Wisdom Financial News APP reported that Shis Pharmaceuticals Group (02005.HK) announced that the group has obtained the drug production registration approval from the China National Medical Products Administration for glucose calcium chloride sodium injection (100ml:1g/0.8g), which belongs to the category 3 chemical drugs and is deemed to have passed consistency evaluation. Glucose calcium chloride sodium injection is mainly used for the treatment of acute hypocalcemia, magnesium poisoning, and fluoride poisoning, and together with the glucose calcium chloride sodium injection (100ml:2g/675mg) approved on June 4, 2025, and the glucose calcium injection (10ml:1g) approved on July 18, 2025, they have collectively built a series of calcium preparation products.